Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism. - Wikidata - awgldk - TriplyDB

Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism.

Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism.

http://www.wikidata.org/entity/Q34355787

about

Neuropharmacology of alcohol addiction Bipolar disorder comorbid with alcoholism: a 1H magnetic resonance spectroscopy study Glutamatergic substrates of drug addiction and alcoholism Treatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as Therapy Glutamatergic targets for new alcohol medications Glial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity?Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy Hangover and risk for alcohol use disorders: existing evidence and potential mechanisms Ethanol-Associated Changes in Glutamate Reward Neurocircuitry: A Minireview of Clinical and Preclinical Genetic Findings.Using an experimental medicine model to understand the antidepressant potential of the N-Methyl-D-aspartic acid (NMDA) receptor antagonist memantine Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder Mesocorticolimbic monoamine correlates of methamphetamine sensitization and motivation.NMDA glutamate receptor antagonism and the heritable risk for alcoholism: new insights from a study of nitrous oxide.The Subjective Response to Nitrous Oxide is a Potential Pharmaco-Endophenotype for Alcohol Use Disorder: A Preliminary Study with Heavy Drinkers Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.Therapeutic infusions of ketamine: do the psychoactive effects matter?Ethanol sensitization in a neurodevelopmental lesion model of schizophrenia in rats Glutamatergic modulators: the future of treating mood disorders?Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics GABA-A and NMDA receptor subunit mRNA expression is altered in the caudate but not the putamen of the postmortem brains of alcoholics Glutamatergic model psychoses: prediction error, learning, and inference Characterization of the interactive effects of glycine and D-cycloserine in men: further evidence for enhanced NMDA receptor function associated with human alcohol dependence.Onset Pattern and Long-Term Prognosis in Schizophrenia: 10-Year Longitudinal Follow-Up Study Ketamine and the next generation of antidepressants with a rapid onset of action N-methyl-D-aspartate receptor antagonism has differential effects on alcohol craving and drinking in heavy drinkers Outpatient Long-term Intensive Therapy for Alcoholics (OLITA): a successful biopsychosocial approach to the treatment of alcoholism.The N-methyl-D-aspartate receptor as a neurobiological intersection between bipolar disorder and alcohol use: a longitudinal mismatch negativity study Novel glutamatergic agents for major depressive disorder and bipolar disorder.Repeated ketamine administration alters N-methyl-D-aspartic acid receptor subunit gene expression: implication of genetic vulnerability for ketamine abuse and ketamine psychosis in humans.Ethanol-like effects of thiopental and ketamine in healthy humans.Impact of family history of alcoholism on glutamine/glutamate ratio in anterior cingulate cortex in substance-naïve adolescents Homer2 regulates alcohol and stress cross-sensitization.Alcohol impairment of saccadic and smooth pursuit eye movements: impact of risk factors for alcohol dependence Family history of alcohol dependence and antidepressant response to an N-methyl-D-aspartate antagonist in bipolar depression Effects of memantine on event-related potential, oscillations, and complexity in individuals with and without family histories of alcoholism.mTOR activation is required for the anti-alcohol effect of ketamine, but not memantine, in alcohol-preferring rats Human biomarkers of rapid antidepressant effects Memantine, an NMDA receptor antagonist, differentially influences Go/No-Go performance and fMRI activity in individuals with and without a family history of alcoholism.Role of major NMDA or AMPA receptor subunits in MK-801 potentiation of ethanol intoxication

P2860

Q22251110-257867CE-F10B-4E79-9D3A-E5C4A23C8C24 Q24630222-FF2B0136-2B2B-4E2C-B72D-4E728C701B74 Q24648924-2CB254B7-7F85-4BED-A8D1-BF66045BB569 Q26773084-A9BCE2C7-CD7A-4075-AEF1-C3AA51AC350B Q26824012-6D847F82-9DD4-4C87-85C0-479E316684F0 Q26829556-4CAA10EE-964C-40E0-A522-5576C2DE166B Q27004490-124B1F1F-CEA2-4485-97A3-2CBA40519738 Q27024227-B10B825B-17F8-4E8E-8FEA-A3C3E73E8744 Q28290604-8C265166-BF01-41B2-B256-20274D25914E Q30367006-7B2A02EF-1CC7-436D-A3A2-69F0176EA4B6 Q30458884-D9A796D0-ACCC-490C-8253-02FB99281748 Q30711088-AE0799A9-7D90-41B0-98DD-47B0B35A3D4C Q33605970-6B63DD13-70D0-4A3A-A686-F2943A9E6BBC Q33614452-9723D04F-D545-49F5-B1DB-8BDF467C2ECC Q33614487-F7C29386-53CA-4227-B00A-9FF20F045348 Q33874459-0F313D4B-FB87-43AD-9656-78E237031C38 Q33880853-F6DF488E-CE33-4074-A07B-724BE44C4BF8 Q33935945-430E1386-D286-47CD-B35B-E09E0F1F9394 Q34398007-6C73C17A-83E9-47F6-93D8-1D92BD145436 Q34444632-9F89CBED-F282-4D61-87DE-8AE98BED2636 Q34637999-27F01B0F-9752-4DA5-9662-7E9D80B4E72D Q34661231-5E3D9ACD-7FFD-47FB-9BDD-27FE1F8B71F6 Q34661868-F0BCD3D5-8FCA-4ADD-B0A6-FB082F714713 Q34806927-0A8C4C4A-1588-4A4D-87D7-EE8FB45FF605 Q34978041-DD83026D-49A3-467F-848A-35A1815E441B Q35091293-0FDE8A69-CC20-4A3C-B4C7-BD60F0289E64 Q35454845-48486D00-9F65-4E29-9CAE-3BDA6EA0694B Q35626959-2B22D2FF-DF1C-406D-B41D-A1A5B45459CA Q35661119-29E513D2-70F5-4EEC-8580-6B758F4936EB Q35747469-16ECD493-ED11-4AF8-BE2C-3270D43C5423 Q35794858-49FFA04B-D9FC-4E36-930C-774FBEB9D4A0 Q36202010-B347C0ED-109D-4C66-8BFE-18DE8F44491A Q36218435-BAE8532D-954E-47D2-B074-4B04A8C9770A Q36249198-7229CBB1-5964-4B7E-BE5A-3352DCA8E4CE Q36417179-84FC69F5-4CFC-4C93-B284-ED2E5F546484 Q36597555-11937ACD-B0A6-4A85-A5D9-3839561CED0F Q36823796-FF0544FA-D003-44A8-9073-B1BD3F5AC1B8 Q36902074-8F5BA045-00B1-4B1A-B55F-47EC3DDE60F8 Q36906101-8792163A-D4B6-4B17-87C3-8B77ABAB1E7C Q36922887-7CD4EAD1-3107-461C-A20D-2C8979AA7C08

P2860

Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism.

http://www.wikidata.org/entity/Q34355787

description

2004 nî lūn-bûn

@nan

2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Altered NMDA glutamate recepto ...... y vulnerability to alcoholism.

@ast

Altered NMDA glutamate recepto ...... y vulnerability to alcoholism.

@en

Altered NMDA glutamate recepto ...... y vulnerability to alcoholism.

@nl

type

label

Altered NMDA glutamate recepto ...... y vulnerability to alcoholism.

@ast

Altered NMDA glutamate recepto ...... y vulnerability to alcoholism.

@en

Altered NMDA glutamate recepto ...... y vulnerability to alcoholism.

@nl

prefLabel

Altered NMDA glutamate recepto ...... y vulnerability to alcoholism.

@ast

Altered NMDA glutamate recepto ...... y vulnerability to alcoholism.

@en

Altered NMDA glutamate recepto ...... y vulnerability to alcoholism.

@nl

P1433

Q34355787-45242948-919F-4E8B-8A35-D852BABE48C0

P1476

Q34355787-43A9A5EC-63B1-489F-8953-1DE54EFB73D1

P2093

Q34355787-0962CE57-9E1F-4781-9C52-B9E624444F7E

Q34355787-0E3B6510-BC42-45FB-A33B-FC93457AB3AE

Q34355787-2211DB6C-2723-45CF-90DB-DD0E81738D45

Q34355787-3E16B66E-6656-4CE6-81B3-965572009CB9

Q34355787-47310041-B879-4027-B4FD-E5D6674AB05C

Q34355787-A5E610E4-A675-494A-B608-109307940D7E

Q34355787-D04BAF50-C2C0-4C72-AABE-F7D8789E9E7F

Q34355787-EB81EC49-0BCA-443B-A074-B908E85F4A9B

P304

Q34355787-2757FDE8-553B-4770-8FC3-87203AA399F8

P31

Q34355787-BC9DB0AF-9BC0-4186-855B-20268CB173B0

P356

Q34355787-B540BA2A-100A-4545-A3A6-3DAFDABF32B9

P407

Q34355787-D3E1F5AA-8DD4-4F9D-B8EC-0A1913EDAF1A

P433

Q34355787-2EFFCDDF-9E11-4EBD-8F6C-503C485CEC70

P478

Q34355787-CFC5189E-D206-4BC2-9874-308FDF5A3236

P577

Q34355787-2E76532C-2E3A-42EC-907D-9885FA9588D9

P698

Q34355787-8B5E8A8C-F478-453B-A517-5ACFD4424A13

P921

Q34355787-0F8A5F30-CF9B-4F67-824E-FCBC36CD398F

Q34355787-75F3FED9-D0A4-404D-B681-FF380A57CB28

P356

AJP.161.10.1776

P1433

American Journal of Psychiatry

P1476

Altered NMDA glutamate recepto ...... y vulnerability to alcoholism.

@en

P2093

Diana Limoncelli

http://www.w3.org/2001/XMLSchema#string

Ismene L Petrakis

http://www.w3.org/2001/XMLSchema#string

Joel Gelernter

http://www.w3.org/2001/XMLSchema#string

John H Krystal

http://www.w3.org/2001/XMLSchema#string

Louis Trevisan

http://www.w3.org/2001/XMLSchema#string

Nashaat N Boutros

http://www.w3.org/2001/XMLSchema#string

Peter Jatlow

http://www.w3.org/2001/XMLSchema#string

Ralitza Gueorguieva

http://www.w3.org/2001/XMLSchema#string

P304

1776-1782

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1176/AJP.161.10.1776

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

161

http://www.w3.org/2001/XMLSchema#string

P577

2004-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15465973

http://www.w3.org/2001/XMLSchema#string

P921